Bioelectronica Announces Hypercell™ Expansion for Antibody Discovery, Closing of Oversubscribed Series A Financing, Powering Local Hiring Growth and Expansion of Facilities in Reno
Jul 19, 2021
Expansion of Hypercell™ for biopharma discovery with software. Establishment of a second site increased lab capacity by over 45% and engineering capacity by over 70%. RENO, Nev. , July 19, 2021 /PRNewswire/ -- Bioelectronica ® Corporation ("Bioelectronica") announced today that it has secured an undisclosed amount in its Series A financing round due to increased interest in Hypercell™, a n...